ProMIS Neurosciences, Inc. (PMN) Revenue History
Annual and quarterly revenue from 2006 to present
PMN Revenue Over Time (2006–2025)
PMN Revenue Growth History
8 of 16 years with positive growth- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- +602.3%
- FY2008 revenue growth
- +111.0%
- FY2009 revenue growth
- -58.3%
- FY2010 revenue growth
- -9.0%
- FY2011 revenue growth
- +598.6%
- FY2012 revenue growth
- -92.6%
- FY2013 revenue growth
- -46.6%
- FY2014 revenue growth
- +175.7%
- FY2015 revenue growth
- -89.3%
- FY2016 revenue growth
- -86.1%
- FY2017 revenue growth
- +293.0%
- FY2018 revenue growth
- -95.6%
- FY2019 revenue growth
- +244.7%
- FY2020 revenue growth
- +30.2%
- FY2021 revenue growth
- +420.0%
- FY2022 revenue growth
- -100.0%
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
PMN Revenue Analysis (2006–2025)
Current Revenue & Growth
As of June 13, 2026, ProMIS Neurosciences, Inc. (PMN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
PMN's historical revenue data shows various trends over time. ProMIS Neurosciences, Inc.'s highest annual revenue of $1.2 million was recorded in 2011.
Peer Comparison
Compared to Healthcare sector peers — including PRTA (-58.0% YoY), ARVN (-79.1% YoY), and ACAD (+9.9% YoY). Compare PMN vs PRTA →
PMN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 PMNCurrent | $0 | - | - | - | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 ARVN | $263M | -79.1% | +58.9% | -43.8% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 NRXP | $1M | - | - | -1324.4% |
PMN Historical Revenue Data (2006–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-40,167,308 | - |
| 2024 | $0 | - | $0 | - | $-16,827,478 | - |
| 2023 | $0 | - | $-10,444,957 | - | $-18,897,693 | - |
| 2022 | $0 | -100.0% | $0 | - | $-23,379,912 | - |
| 2021 | $8K | +420.0% | $-5,843,329 | -71796.9% | $-8,249,673 | -101363.6% |
| 2020 | $2K | +30.2% | $-3,181,584 | -203296.1% | $-5,662,392 | -361814.2% |
| 2019 | $1K | +244.7% | $-4,734,115 | -393853.2% | $-12,131,576 | -1009282.5% |
| 2018 | $349 | -95.6% | $349 | 100.0% | $-7,464,630 | -2140431.6% |
| 2017 | $8K | +293.0% | $8K | 100.0% | $-4,781,604 | -60766.7% |
| 2016 | $2K | -86.1% | $2K | 100.0% | $-2,558,654 | -127799.6% |
| 2015 | $14K | -89.3% | $14K | 100.0% | $-1,511,124 | -10519.5% |
| 2014 | $134K | +175.7% | $134K | 100.0% | $-2,038,522 | -1519.2% |
| 2013 | $49K | -46.6% | $49K | 100.0% | $-2,194,927 | -4510.2% |
| 2012 | $91K | -92.6% | $91K | 100.0% | $-2,563,183 | -2813.9% |
| 2011 | $1.2M | +598.6% | $1.2M | 100.0% | $-3,426,693 | -278.4% |
What if you invested $1,000 in PMN back in 2006?
Total return with dividends reinvested · 20+ years of data
Calculate ReturnsHow much would $100/month in PMN be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs PMN Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationPMN vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowPMN — Frequently Asked Questions
Quick answers to the most common questions about buying PMN stock.
Is PMN's revenue growth accelerating or slowing?
PMN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PMN's revenue history from 2006 to 2026?
ProMIS Neurosciences, Inc. (PMN) revenue history spans 2006 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is PMN's long-term revenue growth rate (CAGR)?
ProMIS Neurosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PMN.
Why does PMN's quarterly revenue fluctuate?
PMN quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. ProMIS Neurosciences, Inc.'s revenue data from 2006 to 2026 shows full historical quarterly detail on this page.
How is PMN's revenue distributed by segment?
PMN reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does PMN's revenue compare to industry peers?
ProMIS Neurosciences, Inc. (PMN) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.